Translational Sciences, Inc.
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Apr 25, 2008 → Jun 27, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9150903B2 | Method of increasing plasmin activity through antiplasmin conversion | Human Necessities | 2 | Active |
| US9834614B2 | Method of increasing plasmin activity through antiplasmin conversion | Human Necessities | 1 | Active |
| US11345758B2 | Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury | Chemistry; Metallurgy | 0 | Active |
| US11078297B2 | Prophylaxis of thrombosis | Human Necessities | 0 | Active |
| US11236176B2 | Serpinf2-binding molecules and method of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.